 |
- Condition: Influenza
Interventions: Drug: Arbidol; Drug: Placebos
Sponsors: Capital Medical University; University of Oxford; Peking University; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention
Recruiting - Condition: Influenza
Intervention: Biological: Quadrivalent inactivated influenza vaccine (IIV)
Sponsors: Stanford University; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - Conditions: Influenza; Influenza-like Illness
Interventions: Biological: Egg based influenza vaccines; Biological: Recombinant influenza vaccines; Biological: Cell-culture based influenza vaccines
Sponsors: Henry M. Jackson Foundation for the Advancement of Military Medicine; National Institute of Allergy and Infectious Diseases (NIAID); Food and Drug Administration (FDA); Defense Health Agency Immunization Healthcare Branch; Armed Forces Health Surveillance Branch; Naval Health Research Center; United States Air Force School of Aerospace Medicine; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; Uniformed Services University of the Health Sciences
Recruiting - Condition: Influenza
Intervention: Biological: FluMist
Sponsors: Stanford University; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - Condition: Severe Influenza
Interventions: Drug: Oseltamivir Phosphate; Drug: Xiyanping injection+Oseltamivir Phosphate
Sponsors: Jiangxi Qingfeng Pharmaceutical Co. Ltd.; The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine; the first affiliated hospital of Liaoning university of traditional Chinese medicine; Beijing Luhe Hospital; Qingdao Municipal Hospital; Cangzhou People's Hospital
Recruiting - Condition: Influenza
Interventions: Drug: Oseltamivir; Biological: MEDI8852; Drug: Placebo
Sponsor: MedImmune LLC
Not yet recruiting - Conditions: Influenza; Flu
Interventions: Biological: Shz QIV 0.25 mL, 2 doses; Biological: Shz QIV 0.5 mL, 2 doses; Biological: Shz QIV 0.5 mL, single dose
Sponsor: Sanofi Pasteur, a Sanofi Company
Recruiting - Condition: Influenza
Interventions: Biological: aTIV Primer; Biological: QIV Primer; Biological: aTIV Booster; Biological: QIV Booster
Sponsors: Canadian Immunization Research Network; Provincial Health Services Authority; McGill University Health Center; Université de Montréal; Canadian Center for Vaccinology; McMaster University; CHU de Quebec-Universite Laval; Dalhousie University
Recruiting - Conditions: Influenza; Influenza Immunisation
Intervention: Biological: Influenza Virus Quadrivalent Inactivated Vaccine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Influenza, Human
Interventions: Biological: Fluzone 0.25 mL dose; Biological: Fluzone 0.5 mL dose; Other: natural influenza infection
Sponsors: University of Rochester; University of Chicago
Recruiting - Conditions: Influenza; Influenza Immunisation
Intervention: Biological: Influenza Virus Quadrivalent Inactivated Vaccine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Influenza
Interventions: Biological: Flucelvax; Other: Human Challenge virus
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Influenza
Intervention: Biological: VRC-FLUNPF099-00-VP (H1ssF_3928)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Influenza
Intervention: Biological: Quadrivalent inactivated influenza vaccine (IIV)
Sponsors: Stanford University; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - Condition: Influenza
Interventions: Biological: MVA-NP+M1; Biological: Saline; Biological: H3N2 (A/Belgium/2417/2015)
Sponsor: Vaccitech Limited
Not yet recruiting - Condition: Influenza
Interventions: Biological: MVA-NP+M1; Drug: Saline
Sponsors: Vaccitech Limited; Clinical Network Services (CNS) Pty Ltd
Recruiting - Condition: Influenza
Interventions: Biological: Quadrivalent influenza vaccine; Biological: Trivalent influenza vaccine A; Biological: Trivalent influenza vaccine B
Sponsor: Shanghai Institute Of Biological Products
Not yet recruiting - Conditions: Influenza; Influenza Immunisation
Intervention: Biological: Influenza Virus Vaccine Inactivated
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Influenza
Interventions: Drug: Oseltamivir; Drug: Paracetamol
Sponsor: Rambam Health Care Campus
Not yet recruiting - Conditions: Influenza; Influenza Immunisation
Interventions: Biological: Advax-CpG55.2; Drug: AF03; Biological: Influenza Virus Quadrivalent Inactivated Vaccine; Biological: Quadrivalent Recombinant Seasonal Influenza Vaccine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - Condition: Influenza
Interventions: Drug: sirolimus and oseltamivir; Drug: Oseltamivir
Sponsor: Chinese University of Hong Kong
Not yet recruiting - Condition: Influenza
Interventions: Biological: QIV-IB; Biological: TIVV-IB; Biological: TIVY-IB; Biological: QIV-IB Lot A; Biological: QIV-IB Lot B; Biological: QIV-IB Lot C
Sponsors: Butantan Institute; Fundação Butantan
Not yet recruiting - Condition: Influenza
Interventions: Biological: Butantan Institute Trivalent Seasonal Influenza Vaccine; Biological: Sanofi Trivalent Seasonal Influenza Vaccine
Sponsor: Butantan Institute
Not yet recruiting - Condition: Influenza
Interventions: Biological: FluBlok; Biological: Fluzone; Biological: FluCelVax
Sponsors: University of Rochester; National Institutes of Health (NIH)
Recruiting - Condition: Influenza
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Post Influenza
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Influenza
Intervention: Drug: Baloxavir Marboxil
Sponsor: Hoffmann-La Roche
Recruiting - Condition: Influenza
Interventions: Drug: Baicalein Tablets 400mg; Drug: Baicalein Tablets 600mg; Drug: blank control 0mg
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Not yet recruiting - Condition: Influenza
Interventions: Drug: Baloxavir Marboxil; Other: Placebo
Sponsor: Hoffmann-La Roche
Recruiting - Conditions: Influenza; Influenza Immunisation
Interventions: Biological: Influenza Virus Monovalent A/H3N2/Bris 10 M2SR Live Vaccine; Other: Placebo; Biological: Quadrivalent MDCK Inactivated Influenza Vaccine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Influenza
Intervention: Biological: H5N1 pISV
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Influenza; Influenza Immunisation
Intervention: Biological: Influenza Virus Vaccine Inactivated
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Influenza
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Ohio State University
Recruiting - Conditions: Influenza Type A; Influenza Type B
Interventions: Device: ALiA Analyser; Device: Influenza A+B Test Kit
Sponsors: Sanwa BioTech Limited; Prince of Wales Hospital, Shatin, Hong Kong; Chinese University of Hong Kong
Not yet recruiting - Conditions: Avian Influenza; Influenza Immunisation
Interventions: Biological: A/H7N9; Drug: MF59 adjuvant; Other: Phosphate Buffered Saline (PBS) diluent
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Influenza
Interventions: Drug: Peramivir; Drug: Oseltamivir
Sponsor: BioCryst Pharmaceuticals
Recruiting - Condition: Influenza
Interventions: Biological: M-001; Biological: Saline
Sponsor: BiondVax Pharmaceuticals ltd.
Recruiting - Condition: Influenza A
Interventions: Drug: Pimodivir 600 mg; Drug: Placebo; Other: SOC Treatment
Sponsor: Janssen Research & Development, LLC
Recruiting - Condition: Influenza A
Interventions: Drug: Pimodivir 600 mg; Drug: Placebo; Other: SOC Treatment
Sponsor: Janssen Research & Development, LLC
Recruiting - Condition: Influenza A
Interventions: Drug: Low dose of VIS410 in addition to oseltamivir; Drug: High dose of VIS410 in addition to oseltamivir; Drug: Placebo in addition to oseltamivir
Sponsor: Visterra, Inc.
Recruiting - Conditions: Influenza; H7N9 Influenza
Interventions: Biological: H7N9 antigen + adjuvant IB160; Biological: H7N9 antigen + adjuvant SE; Biological: H7N9 antigen without adjuvant; Biological: Placebo (PBS)
Sponsor: Butantan Institute
Recruiting - Condition: Influenza
Interventions: Drug: N-acetyl cysteine; Drug: 5% Dextrose
Sponsor: Chinese University of Hong Kong
Not yet recruiting - Conditions: Influenza A H3N2; Influenza A H1N1
Interventions: Biological: FLU-IGIV; Other: Placebo for FLU-IGIV
Sponsor: Emergent BioSolutions
Recruiting - Conditions: Influenza A; Influenza B
Interventions: Biological: Intravenous hyperimmune immunoglobulin (IVIG); Biological: Placebo for IVIG
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); University of Minnesota, MN; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)
Recruiting - Condition: Influenza, Human
Interventions: Other: Blood sample; Other: Nasal swab; Other: Oropharyngeal swab; Other: Stool sample; Other: Symptom checklist
Sponsor: St. Jude Children's Research Hospital
Recruiting - Condition: Influenza
Intervention:
Sponsor: University of Pittsburgh
Recruiting - Condition: H7N9 Influenza
Interventions: Biological: 15μg H7N9 Vaccine; Biological: Aluminum Hydroxide Adjuvant
Sponsor: Shanghai Institute Of Biological Products
Not yet recruiting - Condition: Influenza A Subtype H5N1 Infection
Intervention: Biological: Seasonal Influenza Vaccine
Sponsors: Emory University; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Influenza, Human
Interventions: Drug: Clarithromycin 250 MG; Drug: Placebos
Sponsor: The University of Hong Kong
Not yet recruiting - Condition: Influenza, Human
Interventions: Diagnostic Test: Procalcitonin; Other: Pharmacist-Led Education
Sponsors: University of California, Davis; Roche Pharma AG
Recruiting - Condition: H7N9 Subtype of Influenza A Virus
Intervention: Drug: Pimodivir
Sponsor: Janssen Research & Development, LLC
Available - Condition: Influenza, Human
Intervention: Biological: Fluarix
Sponsor: University of Rochester
Recruiting - Conditions: Influenza; Organ Transplantation
Interventions: Biological: High-dose influenza vaccine; Biological: MF59-adjuvanted influenza vaccine; Biological: Standard intramuscular influenza vaccine
Sponsors: Oriol Manuel; University Hospital, Basel, Switzerland; University of Bern; University Hospital, Geneva; University of Zurich; Cantonal Hospital of St. Gallen; Fondazione Epatocentro Ticino
Recruiting - Condition: Influenza, Human
Interventions: Biological: QIVc; Biological: Comparator
Sponsor: Seqirus
Not yet recruiting - Conditions: Heart Failure; Influenza
Interventions: Other: Sterile saline; Drug: inactivated trivalent influenza vaccine
Sponsor: McMaster University
Recruiting - Conditions: Influenza; Vaccination
Intervention: Behavioral: Text message influenza vaccine reminders
Sponsors: Columbia University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); American Academy of Pediatrics; Children's Hospital of Philadelphia
Recruiting - Condition: Influenza, Human
Interventions: Drug: KT07 Capsule; Other: Placebo
Sponsor: Yiling Pharmaceutical Inc.
Recruiting - Conditions: Influenza; Acute Respiratory Viral Infections
Interventions: Drug: XC221; Drug: Placebo
Sponsor: PHARMENTERPRISES LLC
Recruiting - Conditions: Influenza, Human; Myocardial Injury
Intervention:
Sponsor: Örebro University, Sweden
Recruiting - Condition: Influenza
Interventions: Biological: NBP607-QIV; Biological: Agrippal
Sponsor: SK Bioscience Co., Ltd.
Not yet recruiting - Conditions: Influenza; Acute Respiratory Infection; Influenza-like Illness
Intervention: Behavioral: Educational text messages
Sponsors: Columbia University; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Influenza With Pneumonia; Invasive Pulmonary Aspergillosis
Intervention:
Sponsor: Universitaire Ziekenhuizen Leuven
Recruiting - Conditions: Respiratory Syncytial Virus Infections; Influenza, Human
Interventions: Biological: RSV A Memphis 37; Biological: Influenza A/California/04/2009
Sponsors: Imperial College London; Medical Research Council; Wellcome Trust; National Institute for Health Research, United Kingdom
Recruiting - Condition: Influenza, Human
Intervention: Behavioral: Exercise
Sponsors: University of Houston; National Institute on Aging (NIA)
Recruiting - Conditions: Influenza; Respiratory Virus Syncitial; Extra-respiratory
Intervention: Other: observational
Sponsor: Poitiers University Hospital
Recruiting - Condition: Influenza
Intervention: Other: Data collection
Sponsor: GlaxoSmithKline
Recruiting - Condition: Influenza Viral Infections
Intervention: Diagnostic Test: Sofia Influenza A+B FIA
Sponsors: University of Wisconsin, Madison; Quidel Corporation
Recruiting - Conditions: Influenza; Immunization; Older Adults; Over Age 75
Intervention: Biological: Influenza
Sponsor: Johns Hopkins University
Recruiting - Condition: Influenza
Interventions: Biological: Live attenuated influenza vaccine (LAIV4); Biological: Inactivated Influenza Vaccine (IIV4)
Sponsors: Stanford University; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - Condition: Influenza
Interventions: Diagnostic Test: Ellume Home Flu Test; Diagnostic Test: ellume.lab Flu A+B Test; Diagnostic Test: Reverse Transcriptase Polymerase Chain Reaction (RT-PCR); Diagnostic Test: Viral culture
Sponsor: Ellume Pty Ltd
Recruiting - Condition: Influenza Virus Infection
Intervention:
Sponsor: Renmin Hospital of Wuhan University
Not yet recruiting - Condition: Flu
Interventions: Drug: Oseltamivir; Drug: Diltiazem; Drug: Placebos
Sponsors: University Hospital, Lille; Ministry of Health, France
Recruiting - Condition: Flu
Interventions: Drug: Fluad Vaccine; Drug: Fluzone HD Vaccine
Sponsors: David H. Canaday; Case Western Reserve University; US Department of Veterans Affairs; Brown University; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Influenza, Human; Pregnancy; Birth Defect
Interventions: Biological: Flucelvax Trivalent Influenza Vaccine; Biological: Flucelvax Quadrivalent Influenza Vaccine
Sponsor: Seqirus
Recruiting - Condition: Immunity, Cellular
Intervention: Drug: Influenza Vaccine
Sponsor: Washington University School of Medicine
Recruiting - Condition: Influenza, Human
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Influenza; Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV); Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
Intervention:
Sponsors: University of Minnesota - Clinical and Translational Science Institute; National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH)
Recruiting - Reactogenicity, Safety and Immunogenicity of a LAIV А/17/Hong Kong/2017/75108 H7N9 Influenza VaccineCondition: Vaccine Adverse Reaction
Interventions: Biological: Placebo; Biological: H7N9 LAIV
Sponsors: Research Institute of Influenza, Russia; World Health Organization; Institute of Experimental Medicine, Russia; Joint Stock Company Microgen, Russia
Not yet recruiting - Conditions: Myocardial Infarction; Influenza, Human; Influenza Vaccines; Heart Failure; Stroke
Interventions: Biological: Influenza vaccine; Biological: Placebo
Sponsors: Ole Frobert, MD, PhD; Swedish Heart Lung Foundation; Sanofi Pasteur, a Sanofi Company; Uppsala University; Lytics
Recruiting - Condition: Aspergillosis; Pulmonary, Invasive (Etiology)
Interventions: Drug: SOC +Posaconazole 18 MG/ML (milligram/milliliter); Other: standard of care (SOC)
Sponsors: Universitaire Ziekenhuizen Leuven; Merck Sharp & Dohme Corp.
Recruiting - Conditions: Influenza, Human; Pregnancy; Birth Defect
Intervention: Biological: Afluria Influenza Vaccine
Sponsor: Seqirus
Recruiting - Conditions: Hematopoietic Cell Transplantation Recipient; Malignant Neoplasm; Influenza
Interventions: Biological: Trivalent Influenza Vaccine; Biological: Quadrivalent Influenza Vaccine; Other: Laboratory Biomarker Analysis
Sponsors: Vanderbilt-Ingram Cancer Center; National Cancer Institute (NCI)
Recruiting - Conditions: Heart Failure; Myocardial Infarction
Interventions: Biological: High Dose Trivalent Influenza Vaccine; Biological: Standard Dose Quadrivalent Influenza Vaccine
Sponsors: Brigham and Women's Hospital; National Heart, Lung, and Blood Institute (NHLBI); University of Wisconsin, Madison; University of Toronto; Boston VA Research Institute, Inc.; Patient-Centered Outcomes Research Institute
Recruiting - Condition: Influenza
Interventions: Drug: ZSP1273 100 mg; Drug: Placebo 100 mg; Drug: ZSP1273 200 mg; Drug: Placebo 200 mg; Drug: ZSP1273 400 mg; Drug: Placebo 400 mg; Drug: ZSP1273 600 mg; Drug: Placebo 600 mg; Drug: ZSP1273 900 mg; Drug: Placebo 900 mg; Drug: ZSP1273 1200 mg; Drug: Placebo 1200 mg; Drug: ZSP1273; Drug: Placebo; Drug: ZSP1273 Low Dose; Drug: ZSP1273 Median Dose; Drug: ZSP1273 High Dose
Sponsor: Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Recruiting - Condition: Influenza
Interventions: Biological: Vaccine administration by a pharmacist; Behavioral: Unmet vaccination needs identified and met; Behavioral: Vaccination forecast review and patient education
Sponsor: American Pharmacists Association Foundation
Recruiting - Conditions: Asthma in Children; Vaccine Adverse Reaction; Vaccine Reaction; Asthma; Wheezing; Influenza
Interventions: Biological: Live Attenuated Influenza Vaccine (LAIV); Biological: Inactivated Influenza Vaccine (IIV)
Sponsors: Vanderbilt University Medical Center; Centers for Disease Control and Prevention; Duke University; Children's Hospital Medical Center, Cincinnati
Recruiting - Conditions: Depression; Healthy
Intervention: Biological: Influenza Vaccine
Sponsor: University of Texas at Austin
Not yet recruiting - Conditions: Influenza; Pneumonia; Lower Respiratory Tract Infection; Acute Myocardial Infarction; Congestive Heart Failure; Stroke
Interventions: Biological: Flublok Quadrivalent; Biological: Standard Dose Inactivated Influenza Vaccine (SD-IIV)
Sponsors: Kaiser Permanente; Sanofi Pasteur, a Sanofi Company
Recruiting - Condition: Inflammatory Bowel Diseases
Interventions: Biological: Pneumococcal Pneumonia vaccine; Biological: Influenza vaccine; Biological: Hepatitis B vaccine
Sponsor: Boston Medical Center
Recruiting - Conditions: Vaccination; Infection
Interventions: Other: Standardised Digital Intervention; Other: Individualised Digital Intervention
Sponsors: University of Nottingham; Public Health England
Not yet recruiting - Conditions: Chronic Lymphocytic Leukemia; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Mantle Cell Lymphoma; Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
Intervention: Biological: Inactivated Influenza Vaccine
Sponsor: Emory University
Recruiting - Conditions: Respiratory Pathogens; Upper Respiratory Tract Illness; Lower Respiratory Tract Illness; Acute Respiratory Infection
Intervention: Diagnostic Test: Results available to provider
Sponsors: University of Colorado, Denver; Biofire
Recruiting - Conditions: Pain; Quality of Life; Injection Site Reaction; Side Effect of Drug; Adverse Drug Event
Interventions: Biological: FLUAD; Biological: Fluzone High-Dose
Sponsors: Duke University; Centers for Disease Control and Prevention; Boston Medical Center; Children's Hospital Medical Center, Cincinnati
Recruiting - Condition: Clinical Decision Support
Interventions: Other: Current Version of the Influenza Alert; Other: Alternate Modifications of the Influenza Alert
Sponsor: New York University School of Medicine
Recruiting - Condition: Healthy Volunteers
Intervention: Drug: Bimekizumab
Sponsor: UCB Biopharma S.P.R.L.
Not yet recruiting - Condition: Systemic Inflammatory Response
Interventions: Biological: Influenza Vaccine; Drug: Placebo
Sponsor: Health Sciences North Research Institute
Recruiting - Condition: Abdominal Cancer
Interventions: Drug: Cialis; Biological: Influenza vaccine
Sponsor: Ottawa Hospital Research Institute
Recruiting - Condition: Juvenile Idiopathic Arthritis
Intervention: Biological: Influenza vaccine, Immune function
Sponsor: University of Pecs
Recruiting - Conditions: Rheumatologic Disorder; Inflammatory Bowel Diseases; Immune Complex Diseases
Intervention: Biological: Influenza vaccine
Sponsors: Stony Brook University; University of North Carolina, Chapel Hill
Recruiting - Conditions: Obstructive Sleep Apnea; Hypertension
Interventions: Other: Hand grip isometric contraction; Other: Control
Sponsor: University of Pernambuco
Recruiting - Conditions: Pain; Muscle Strength; Lateral Epicondylitis; Kinesio Taping
Interventions: Device: ESWT; Other: Kinesiotaping Application
Sponsor: Ankara Yildirim Beyazıt University
Not yet recruiting - Conditions: Basilar Thumb Arthritis; Wrist Fracture; Measure Pressure Distribution and Resultant Forces Needed
Intervention:
Sponsor: Shaare Zedek Medical Center
Not yet recruiting - Conditions: Smoking Cessation; Smoking, Cigarette; Smoking; Stress; Stress, Psychological; Health Behavior; Smoking, Tobacco
Interventions: Behavioral: Stress management program (SM); Behavioral: Stress management + Buddy program (SM-B)
Sponsors: Erasmus Medical Center; Indigo Rijnmond, the Netherlands; Avant Sanare, The Netherlands; Erasmus University College, The Netherlands
Recruiting - Condition: PTEN Hamartoma Tumor Syndrome
Intervention: Biological: Influvac Tetra
Sponsor: Radboud University
Not yet recruiting - Condition: Hematopoietic Cell Transplantation
Interventions: Biological: Quadrivalent Inactivated Influenza Vaccine; Other: Laboratory Biomarker Analysis; Biological: Trivalent Influenza Vaccine
Sponsor: Vanderbilt-Ingram Cancer Center
Recruiting - Condition: Rehabilitation, Tenodesis, Stroke
Intervention: Other: Motor task specific training
Sponsor: National Cheng-Kung University Hospital
Recruiting - Condition: Stress
Interventions: Behavioral: R-CBSM; Biological: Influenza vaccine
Sponsors: University of Miami; Florida Department of Health
Recruiting - Conditions: Lower Respiratory Tract Infection; Para Influenza; Immunocompromised
Interventions: Drug: DAS181; Drug: Placebo
Sponsor: Ansun Biopharma, Inc.
Not yet recruiting - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Interferon Beta-1A; Other: Placebo
Sponsor: Synairgen Research Ltd.
Recruiting - Conditions: Virus Diseases; RNA Virus Infections; Respiratory Tract Diseases; Respiratory Tract Infections
Interventions: Biological: Quadrivalent VLP Vaccine; Biological: Quadrivalent Comparator Vaccine
Sponsor: Medicago
Recruiting - Conditions: Bone Mineral Density; Grip Strength; Physical Performance
Intervention: Diagnostic Test: Bone densitometry measurement
Sponsor: Centre Hospitalier Régional d'Orléans
Not yet recruiting - Conditions: Refractory Hematologic Cancer; Allogeneic Stem Cell Transplantation
Intervention: Drug: CLAME-FluBu
Sponsor: Shanghai Jiao Tong University School of Medicine
Recruiting - Conditions: Acute Myeloid Leukemia in Remission; Myelodysplastic Syndromes; Chronic Myeloid Leukemia in Remission; Myeloproliferative Syndrome; Myeloproliferative Disorder; Acute Lymphoid Leukemia in Remission; Multiple Myeloma; Chronic Lymphoid Leukemia; Non Hodgkin Lymphoma; Hodgkin Lymphoma
Interventions: Drug: Thymoglobulin; Drug: Melphalan; Drug: Fludarabine
Sponsors: University of Liege; Belgian Hematological Society Transplant Committee
Recruiting - A Post-Authorization Safety Study of Interferon Beta Therapy in Participants With Multiple SclerosisCondition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: SC Peginterferon beta-1a; Drug: SC interferon beta-1a; Drug: SC interferon beta-1b
Sponsors: Biogen; AMS Advanced Medical Services GmbH
Recruiting - Conditions: Sore Throat; Dysuria; Cough; Common Cold; Influenza
Interventions: Other: Physical Consultation; Other: Online Consultation
Sponsors: Region Skane; Doctrin; Capio Group; Capio Go; Lund University
Recruiting - Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Metformin/Vildagliptin
Sponsor: Clinision
Not yet recruiting - Conditions: Cold; Cold Symptom; Flu; Flu Symptom; Supplement; Stress; Gastrointestinal Tolerance
Interventions: Dietary Supplement: Beta-Glucan; Dietary Supplement: Placebo
Sponsors: Kemin Foods LC; KGK Science Inc.
Recruiting - Conditions: Tuberculosis; Diphtheria; Tetanus; Pertussis; Hepatitis B; Haemophilus Influenzae Type b Infection; Pneumonia, Bacterial; Measles; Rotavirus Infections; Polio; Yellow Fever
Intervention: Behavioral: All Babies are Equal Initiative (conditional cash transfer program)
Sponsors: GiveWell; New Incentives; All Babies are Equal Initiative
Recruiting - Conditions: Tetanus; Diphtheria; Pertussis; Poliomyelitis; Bacterial Meningitis
Interventions: Biological: DPT-IPV-Hib; Biological: Hib vaccine; Biological: DPT-IPV
Sponsors: Mitsubishi Tanabe Pharma Corporation; The Research Foundation for Microbial Diseases of Osaka University
Recruiting - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Dietary Supplement: oral probiotics; Drug: aerosol inhaled amikacin; Biological: combined vaccination
Sponsors: Shanghai Zhongshan Hospital; The First Affiliated Hospital of Guangzhou Medical University; Ruijin Hospital
Not yet recruiting - Condition: Obesity
Interventions: Biological: Quadrivalent Influenza Vaccine; Biological: DTP Vaccine (Multiple Actives)
Sponsors: Women's and Children's Hospital, Australia; Sanofi Pasteur, a Sanofi Company
Recruiting - Conditions: Adenovirus; Anesthesia; Anxiety; Anxiolysis; Autism; Autistic Disorder; Bacterial Meningitis; Bacterial Septicemia; Benzodiazepine; Bipolar Disorder; Bone and Joint Infections; Central Nervous System Infections; Convulsions; Cytomegalovirus Retinitis; Early-onset Schizophrenia Spectrum Disorders; Epilepsy; General Anesthesia; Gynecologic Infections; Herpes Simplex Virus; Infantile Hemangioma; Infection; Inflammation; Inflammatory Conditions; Intra-abdominal Infections; Lower Respiratory Tract Infections; Migraines; Pain; Pneumonia; Schizophrenia; Sedation; Seizures; Skeletal Muscle Spasms; Skin and Skin-structure Infections; Treatment-resistant Schizophrenia; Urinary Tract Infections; Withdrawal; Sepsis; Gram-negative Infection; Bradycardia; Cardiac Arrest; Cardiac Arrhythmia; Staphylococcal Infections; Nosocomial Pneumonia; Neuromuscular Blockade; Methicillin Resistant Staphylococcus Aureus; Endocarditis; Neutropenia; Headache; Fibrinolytic Bleeding; Pulmonary Arterial Hypertension; CMV Retinitis; Hypertension; Chronic Kidney Diseases; Hyperaldosteronism; Hypokalemia; Heart Failure; Hemophilia; Heavy Menstrual Bleeding; Insomnia
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
Sponsors: Daniel Benjamin; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); The EMMES Corporation
Recruiting - Conditions: Haemopoietic Stem Cell Transplantation; Allograft
Intervention: Drug: 4th dose of hexavalent vaccine 1 month after the 3rd dose
Sponsors: University Hospital, Grenoble; Centre Hospitalier Universitaire de Nice; University Hospital, Clermont-Ferrand; University Hospital of Saint-Etienne; Centre Hospitalier Universitaire de Besancon
Recruiting - Conditions: Head and Neck Squamous Cell Carcinoma; Head and Neck Cancer
Interventions: Drug: Tadalafil; Biological: Anti-MUC1 Vaccine; Biological: Anti-Influenza Vaccine; Other: Tadalafil Placebo; Other: Vaccine Placebo; Procedure: Peripheral Blood Collection; Procedure: DTH Skin Test; Procedure: Tumor specimen collection
Sponsor: Donald T. Weed
Recruiting - Condition: Respiratory Disorders
Interventions: Biological: GSK's investigational non-typeable Haemophilus influenzae (NTHi) and Moraxella catarrhalis (Mcat) multi-antigen vaccine (GSK3277511A) adjuvanted with AS01E; Biological: Shingrix GSK's lyophilized formulation of the herpes zoster (HZ) vaccine (GSK1437173A)
Sponsor: GlaxoSmithKline
Not yet recruiting - Conditions: Metabolic Myopathies; Exercise Test; Myalgia
Interventions: Device: functional test; Genetic: matching genotype with phenotype
Sponsor: University Hospital, Brest
Recruiting - Condition: Brain Tumor
Interventions: Procedure: Electrocorticography (ECoG) with PMT Grids; Procedure: Electrocorticography (ECoG) with CorTec Grids; Procedure: Digital Glove Procedure; Procedure: Neurological Exam; Procedure: Electrocorticography (ECoG) with Ad-Tech Grids; Procedure: Direct Electrical Stimulation Mapping; Procedure: Grip Sensor Procedure
Sponsor: M.D. Anderson Cancer Center
Recruiting - Condition: Diffuse Intrinsic Pontine Glioma (DIPG)
Interventions: Biological: TTRNA-DC vaccines with GM-CSF; Biological: TTRNA-xALT; Drug: Cyclophosphamide + Fludarabine Lymphodepletive Conditioning; Drug: Dose-Intensified TMZ; Drug: Td vaccine; Biological: Autologous Hematopoietic Stem Cells (HSC)
Sponsors: University of Florida; Accelerate Brain Cancer Cure; Lyla Nsouli Foundation
Recruiting
Clinical Trial Locations